China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong
· Delayed Price · Currency is HKD 7.81
+0.33 (4.41%)
Jun 9, 2025, 4:08 PM HKT
HKG:2877 Revenue
In the year 2024, China Shineway Pharmaceutical Group had annual revenue of 3.78B CNY, down -16.35%. China Shineway Pharmaceutical Group had revenue of 1.69B in the half year ending December 31, 2024, a decrease of -20.80%.
Revenue
3.78B CNY
Revenue Growth
-16.35%
P/S Ratio
1.41
Revenue / Employee
1.17M CNY
Employees
3,220
Market Cap
5.65B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.78B | -738.50M | -16.35% |
| Dec 31, 2023 | 4.52B | 565.90M | 14.32% |
| Dec 31, 2022 | 3.95B | 727.09M | 22.56% |
| Dec 31, 2021 | 3.22B | 567.85M | 21.38% |
| Dec 31, 2020 | 2.66B | -50.30M | -1.86% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| CSPC Pharmaceutical Group | 28.99B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |